July 17, 2020

Croup Treatment Market Expected to Witness a Sustainable Growth by 2030

Croup Treatment Market: Introduction

  • Croup is a medical condition that refers to an infection of the upper airway, which further disrupts breathing, thereby resulting into barking cough. Croup typically occurs in children and is often treatable at home. Symptoms of croup include swelling around the larynx (voice box), windpipe, and bronchi. The cough forcible tries to move through the passageway and swollen vocal cords, which results into a seal-like barking noise. Other symptoms include fever, hoarse voice, and noisy breathing. The croup condition lasts for three to five days normally. Children between the ages of 6 months and 3 years are at higher risk of getting croup, as children have small airways, and they are most susceptible to acquire the symptoms.
  • Croup is commonly caused by parainfluenza virus and is easier to contract through droplets in the air. Sanitization and continuous hand washing are few preventive measures against croup. As per NCBI research published in April 2020, in the U.S., annually croup accounts for 7% of hospitalizations in children below 5 years of age. Laryngotracheitis, laryngotracheobronchitis, and laryngotracheobronchopneumonitis are covered under the croup spectrum. Croup is a highly common respiratory illness caused most commonly by viruses and a few by bacteria too. Parainfluenza virus caused primarily type 1 and type 2 viral croup, and other viruses’ causes’ adenovirus, influenza A and B, measles, and respiratory syncytial virus. The bacteria caused laryngeal diphtheria, laryngotracheobronchitis, bacterial tracheitis, and laryngotracheobronchopneumonitis croup.

Request Sample Of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77740

Key Drivers and Restraints of Global Croup Treatment Market

  • Rise in prevalence of croup diseases, especially in children between the ages of 6 months and 3 years is projected to drive the global croup treatment market. According to NCBI data published in April 2020, croup affects around 3% of children every year, globally. Moreover, parainfluenza virus accounted for 75% of croup infections in children. Majority of cases reported were estimated to be higher in males than females, and approx., 85% of croup cases registered were mild croup. This is likely to boost the need for treatment of croup condition. Furthermore, around 15% of respiratory infections in children was caused due to croup.
  • Availability of generic medication and other treatment, including oxygen therapies and intubation, is estimated to offer treatment for croup. Additionally, awareness related to croup and guidelines related to the treatment of croup is estimated to propel the croup treatment market globally.

Request the Coronavirus Impact Analysis on this Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77740

North America to Lead Global Croup Treatment Market

  • In terms of region, the global croup treatment Market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global croup treatment market during the forecast period due to an increase in prevalence of croup disease especially in children across the region. As per NBCI research in April 2020, croup is likely to affect around 3% of children every year in the U.S. Moreover, in the U.S., croup accounted for 15% emergency department visits. Moreover, rising respiratory conditions in the U.S. is anticipated to propel the market of croup treatment in the region Availability of generic medicines such as corticosteroids, epinephrine, and other medicines for treatment of croup condition would boost the market in the region.
  • Europe was the second-largest market for croup treatment followed by Asia Pacific, owing to the rising prevalence of condition in winters, and especially among children in the region. As per Royal College of Emergency Medicine’s, in the U.K., 80% of children with symptoms of acute onset of stridor and cough are likely to have croup. Furthermore, croup is estimated to occur in 2% of children between the ages of 6 months and 36 months in the U.K. Moreover, male to female ratio of acquiring croup is 3:2.

Pre Book _ Research Report Now – https://www.transparencymarketresearch.com/checkout.php?rep_id=77740&ltype=S

Key Players Operating in Global Croup Treatment Market

The global croup treatment market is fragmented, owing to the presence many large- and small-sized players. Major players operating in the global croup treatment market are:

  • Mylan N.V
  • Ethypharm Group Company
  • Rosemont Pharmaceuticals Ltd,
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Smiths Medical
  • Boehringer Ingelheim International GmbH
  • Hikma Pharmaceuticals
  • Sanofi

More Trending Reports by Transparency Market Research – http://www.prnewswire.com/news-releases/tmr-forecasts-robust-growth-for-the-continuous-renal-replacement-therapy-market-rise-in-acute-kidney-injuries-to-drive-7-0-cagr-during-2019-2027–301021442.html

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/